Proteome Sciences is a CRO specializing in the analysis of proteins detected by Mass Spectrometry. We offer various Discovery and Targeted Services to characterize proteins and their associated post-translational modifications. By using LC-MS2, SysQuant®, and TMTcalibratorTM methodologies we can detect up to 8,000 of proteins/sample. With our proprietary bioinformatics software, these can be trimmed down to some tens of proteins that are either up- or down-regulated with disease progression or drug treatment.
Ultivue provides researchers and scientists with multiplex biomarker assays for tissue phenotyping and digital pathology. Ultivue’s InSituPlex® technology eliminates the need for assay development and enables scientists to unmask and analyze the true biological context of tissue samples. UltiMapper™ kits are fully optimized mIHC panels that provide uninhibited co-localization of multiple markers for deep single-cell phenotyping.
Lonza Bioscience Solutions provides life science researchers with the tools they need to develop and test therapeutics, from basic research to final product release. Lonza’s bioscience products and services range from cell culture and discovery technologies for research, to quality control tests and software for biomanufacturing. Bioscience Solutions serves research customers worldwide in pharmaceutical, biopharmaceutical and biotechnology companies, as well as academic and government research institutions. Primary brands include Clonetics™ Primary Cells, BioWhittaker™ Media, RAFT™ 3D Cell Culture System, Nucleofector™ Transfection Technology, MycoAlert™ Mycoplasma Detection Assay, PyroGENE™ rFC Endotoxin Detection Assay, PyroTec™ PRO Robotic Solution and WinKQCL™ Endotoxin Testing Analysis Software, MODA™ Environmental Monitoring Solutions.
Miltenyi Biotec is a global provider of products and services that advance biomedical research and
cellular therapy. For over 25 years, our innovative tools have been used to obtain, analyze, and
utilize cells. 2,000 employees in 15 international locations are dedicated to helping researchers and
clinicians make a greater impact on science and health
Myriad RBM, Inc. is a CLIA certified, multiplexed immunoassay testing laboratory that solves complex drug development challenges with innovative biomarker services. Myriad RBM’s internally developed and manufactured immunoassay kits based on Multi-Analyte Profiling (MAP) and ultrasensitive Single-Molecule Array (SimoaTM) technology, provide reproducible and quantitative data for hundreds of human proteins.
TransCure bioServices (TCS) provides predictive in vivo pharmacology expertise for drug pre-clinical candidate selection in the fields of infectious, cancer (IO, PDX), inflammation, vaccine and immune disease areas. We are the only preclinical CRO providing commercially HIV, immuno-oncology (IO) therapy, PDX, IBD, vaccine and autoimmune mouse models with a fully functional reconstituted HUMAN IMMUNE SYSTEM (hu-mouse models). We co-design study protocols/experiments performing the ordered studies and providing comprehensive data collection, data analysis and reports.
PromoCell is the premier manufacturer of cell culture products. PromoCell offers broad range of human primary cells, stem cells and blood cells, optimized cell culture media, and a comprehensive line of cell biology research products. Our cell culture products provide scientists with physiologically accurate models, and therefore enable them to obtain better research results. As the original manufacturer, PromoCell is committed to the highest possible ethical and legal standards
Marks & Clerk are committed to providing exceptional intellectual property advice around the
world, helping you to navigate the complexities of IP, patents, trade marks and design protection.
Innovation is the life-blood of business and it’s vital that you do not overlook the need to protect your
intellectual property. From the capture of an idea, to the enforcement or defence of rights in disputes
Marks & Clerk is your expert partner to ensure your IP is protected and fully exploited. Today’s local
is tomorrow’s global – and with our diverse team of practitioners, you’re always supported by a
network of experts.
We accelerate precision medicine by helping researchers, pharmaceutical companies and clinicians discover and make new medicines and therapies. We provide expertise, technology and services for a wide range of areas within the life sciences industry, including the manufacture of contrast agents for diagnostic imaging, basic research of cells and proteins and technologies that enable large-scale manufacturing of vaccines, biologics and cell therapy. The emergence of cell therapy as a frontline treatment for challenging diseases, including cancer, is rapidly changing the healthcare landscape. Our Cell Therapy business provides the tools, technology and processes to enable customers from pharmaceutical manufacturing as part of our Cell Processing segment, to clinicians and technicians in our Cell Banking and Point of Care business segments. We are investing in the field for the long-term, and partnering with pharma, biotech and clinical researchers. GE brings expertise in quality, global distribution, research and development and regulatory that will transform cell therapy from small-scale treatment to a globally accessible personalized medicine.
Champions Oncology provides an end-to-end range of research and development solutions and services, from cell lines to modeling treatment in the clinic using PDX models, that improve the productivity of oncology drug development. Using both in vitro and in vivo testing platforms, companies can leverage the expertise at Champions Oncology to help guide decision making for clinical development scenarios. Champions Oncology is your partner in meeting today’s needs and innovating for tomorrow’s challenges.
Mi-mAbs is an innovative integrated immunotechnology (a consortium) center designed to accelerate the development of new immunotherapy antibodies (mAbs, ADC, Bi-specifics) against cancer and inflammatory diseases. Open to the best targets of academic and industrial research, Mi-mAbs generates antibodies and validate them. Mim-Abs, a multi-disciplinary team, involving experts in hybridoma, molecular biology, biochemistry, immunochemistry and in vitro/in vivo immunopharmacology.
KDBIO is the European distributor for the FiberCell hollow fibre bioreactor enabling mAb production in the range 100mg to grams. This system fits in an incubator and supports continuous culture of hybridomas, CHO or HEK cells at very high cell density. Cell-secreted products are harvested at 50-100X the concentration of flask culture media with “in-vivo like” culture conditions favouring the correct folding, assembly and uniform glycosylation of “difficult-to-express” proteins. Manufacturer: FiberCell Systems, USA. www.kdbio.com
From research to therapy, Horizon Discovery drives the application of gene editing and gene modulation. Innovative tools and services enable scientists to gain a greater understanding of the genetic drivers behind disease, develop and validate diagnostic workflows, and deliver new therapies for precision medicine.
MBL International Corporation (MBLI) is a leading life science company focused on providing solutions for researchers in the life sciences, drug discovery and development and clinical diagnostics fields. Our special emphasis is on immunology, immuno-oncology, oncology and autoimmune disease areas.
At Synthace, we harness the power of the digital world to empower biologists to leverage the potential of research. Our software platform, Antha, brings digitisation and automation to facilitate complex experimental design and execution. Antha conducts experiments in a reproducible way, linking lab equipment, protocols and processes, thereby allowing vast and speedy development, enhancing productivity for research and manufacturing of cell and gene therapy.
We have partnered with Microsoft, Merck, Oxford Biomedica, Cambridge Consultant and Cell Gene Therapy Catapult to optimise their research process and unleash the full potential of the hardware.
Thermo Fisher Scientific provides industry-leading solutions for drug development, clinical trial logistics and commercial manufacturing to customers through our Patheon brand. Our Patheon Viral Vector Services business (formerly Brammer Bio) specializes in CDMO services for companies developing gene-modified cell therapies and in vivo gene therapies. Our key offerings include process and analytical development, clinical and commercial supply of viral vector drug substance and drug product, and regulatory support, enabling our clients to bring novel medicines to market.
is an immuno-oncology diagnostic company providing oncologists and Biopharma with first-in-class immune-based diagnostic products and services to guide cancer care and contribute to precision medicine in the era of immuno-oncology and combination therapies.
For its Biopharma partners, HalioDx has developed the Immunogram, a clinical research platform allowing multimodal analysis to understand the tumor microenvironment. It integrates Immunoscore® assays, innovative technologies like Multiplex Spatial Tissue Analysis (Brightplex®) and molecular testing (NGS, Immunosign® Gene Expression Signatures).
Aquila BioMedical, a Concept Life Sciences company, is an innovative, preclinical contract research organisation, offering clients world-leading research expertise in immunology, immuno-oncology, neuroscience and specialist multiplex histology.
We offer customised and tailored services combining advanced models with protocolled techniques. The result? High-value data allowing you to define the efficacy and the mechanism of action of drug/antibody candidates. Partner with us to benefit from expert advice and interpretation of data from superior and experienced scientists.